BUENA PARK, CA--(Marketwire - Mar 16, 2012) - SOHM, Inc. (PINKSHEETS: SHMN) is a globally known generic pharmaceutical manufacturer, developer and marketer having a vast range of products, covering almost all the therapeutic segments, has grown strength by strength with its thriving acquisitions and strategic tie-ups.
As part of expansions, SOHM has made a strategic alliance with a US FDA approved plant and is entering into the USA generic market. The company has been in negotiations with one of the large pharmaceutical distributors in the USA for supplying its generic products into the US market.
Mr. Shailesh Shah, President & C.E.O., SOHM, Inc., expresses, "SOHM actively reviews pharmaceutical patents and seeks opportunities to introduce its generic products where the patents have expired or are invalid." He adds, "Our strong customer relationship, quality generic products and synched supply chain management have helped us in creating successful track records during the past few years."
SOHM, with the announcement of its Outlook for year 2012, has projected to generate increased revenue by 100% and profitability in the year 2012 and beyond. SOHM will be adopting new technologies as well as plans to invest more towards R&D and quality control procedures. On the other hand, the market strategies are becoming more and more broad with the intention to enter in the Generic Market with strong corporate alliances.
It's been over 25 years since US FDA (Food & Drug Administration) has been approving generic pharmaceutical brands. With the help of generic versions of prescription drugs, the consumers can actually reduce their cost, ranging from 30% to 80%, and still get the same quality medicine.
About SOHM, Inc.
SOHM, Inc., a growing generic pharmaceutical manufacturing and marketing company, has its global presence with a goal to gain continuous growth. The company has its presence in versatile healthcare segments such as Nutraceuticals, Dermatology and all other major therapeutic segments. SOHM is headquartered in North America along with its manufacturing units in India. SOHM's generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia mainly. To know more about SOHM, Inc., please visit www.SOHM.com
This press release is containing many safe harbour statements such as, "project", "plan", "can", etc., keeping in mind the guidelines of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Such statements are subject to possible uncertain risks that may vary actual results from those intended in or expressed by the forward-looking statements. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.